Basing themselves on the absolute harmlessness of OIO as a contraceptive means, the authors also apply it to certain menstrual disorders. This has caused a favourable influence on 48 women with hypermenorrhoea, 49 - with dysmenorrhoea, 44 - with ovarian dysfunction, 7 - with praemenstrual syndrome and 12—with dysfunctional haemorrhagia. Very encouraging are the results of the treatment of 21 cases with juvenile haemorrhagia and 17 - with such haemorrhagia during the climacter.
Василев, Д. — Антиконцепционна профилактика на нежелателната бременност и на абортите по желание, Съвр, мед., 1967, XVIII, бр. 11, с. 932-941.
Кватер, Е. И. — О механизмах овулации, Ак. и гин., Москва, 1965, № 5, с. 107—116.
Папазов, Б., Н. Марковска - Съвременно състояние на въпроса за антиконцепцията, В. Обзори по ак. и гин.. 1966, с. 70-99.
Тодоров, Д. — Съвременни биологични противозачатъчни средства, Съвр. мед.. XVII, 1966, бр 10, с. 854-865.
Americh, J. — De la contraception, Symposium Ciba, v. 11, No, 1, 1963, p. 13-21.
Lloyd, Q. — Oral contraceptives and coronary trombosis., Brit. Med. J ., 1965, 5131, p. 587-588.
Mauvais, P., J. Decourt — Sem. Hop., Paris, 1964, 40, 66, p. 2659-2669.
Nartivet, F. - Brit. Med. J., 1965, 5426, p. 60-61.
Netter, A., J. Salomon— Rev. pract. (Paris), 1963, 12, p. 1457.
Ockner, R. K., C. S. Davidson — N. England J. Med.. 276, 1967, p. 331.
Rivah, L., J. H. Wibson, O. M. Kavasaki — Amer. J. Obst. Gynec., 1963, 82, 102.
Snoeizin g, R. — Organoraina, V. 4, No. 2, p. 4-7.
Email this article (Login required) 
